Medtronic Investors Sue Over Insulin Pump Recall, FDA Letter

By Elliot Weld (September 9, 2022, 5:34 PM EDT) -- Medtronic was hit with a proposed class action Thursday by a group of pension funds alleging the medical device manufacturer hid that its insulin pumps were defective, causing its stock to tank when the U.S. Food and Drug Administration issued a warning letter....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!